VitrofluidiX joined bio:cap in Berlin, bringing together the biotech community to discuss the future of financing, innovation, and company building in Europe.
Throughout the event, one topic came up again and again: Europe has world-class science, but there is still work to do when it comes to translating innovation into successful companies and real-world impact.
There was a clear sense that the European biotech ecosystem is at an important turning point. While ongoing changes bring new challenges, they also create exciting opportunities for companies, researchers, investors, and innovators. ✨
A big thank you to everyone who stopped by the VitrofluidiX booth and took the time for inspiring conversations. We are leaving Berlin with exciting follow-ups, new connections, and plenty of curiosity about what comes next. 🔬
Thank you to the bio:cap and Messe Berlin teams for organizing such a great event.